ArticleBlood cancer journal2023

In-class transition (iCT) of proteasome inhibitor-based therapy: a community approach to multiple myeloma management.

Robert M Rifkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.